AIM Admission - First Day of Dealings

RNS Number : 2577H

Revolymer PLC

10 July 2012

 



10 July 2012

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, THE REPUBLIC OF IRELAND, JAPAN OR AUSTRALIA

Revolymer plc

("Revolymer" or "the Group")

First day of dealings and completion of placing

Revolymer, the British polymer company developing products for a number of high value fast moving consumer goods (FMCG) markets, is pleased to announce that, further to its announcement on 4 July 2012, admission and unconditional dealings in its Ordinary Shares have commenced at 8.00am today on the AIM market of the London Stock Exchange plc ("Admission").

Revolymer also announces that the placing announced on 4 July 2012 ("Placing") has become unconditional in all respects.

Summary

·     Revolymer has placed a total of 25,000,000 ordinary shares ("Placing Shares") with institutional investors at a price of 100 pence per Placing Share ("Placing Price") to raise gross proceeds of £25.0 million.

·     Based on the Placing Price, the market capitalisation of Revolymer on Admission was approximately £53.0 million.

·     The number of ordinary shares in issue immediately after Admission is 53,015,170.

·     Revolymer will use the net proceeds of the Placing primarily to expand the distribution of the Group's confectionery gum products in the United States and into Europe, to fund additional regulatory dossiers in connection with its nicotine gum commercialisation, and to fund the development of its consumer specialties products.

·     The Group's trading symbol is "REVO" and ISIN code is GB00B84LVH87.

·     Panmure Gordon (UK) Limited ("Panmure Gordon") is acting as Nominated Adviser and Broker to Revolymer.

Further information about the Group, including all of the information required to be disclosed pursuant to AIM Rule 26, is available on Revolymer's website, www.revolymer.com.

Revolymer plc	[phone]
Roger Pettman Rob Cridland
Panmure Gordon (UK) Limited	[phone]
Callum Stewart / Adam James (Corporate Finance) Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)
Citigate Dewe Rogerson	[phone]
Ginny Pulbrook / David Dible

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. The Group is generating revenues from the launch of its initial product in the US and expects to launch new products within Europe in the near term.

Important notice

This announcement has been prepared by, and is the sole responsibility of, Revolymer. No undertaking, representation or warranty or other assurance, express or implied, is made or given by or on behalf of Revolymer, Panmure Gordon or any of their respective directors, officers, partners, employees, agents or advisers or other person as to the accuracy completeness or fairness of the information or opinions contained in this announcement and no responsibility or liability is accepted for any such information or opinions. Nothing set out above shall exclude liability for any undertaking, representation or warranty or other assurance made fraudulently.

This announcement does not constitute, or form a part of, any offer or invitation to sell, allot or issue, or any solicitation of any offer to purchase or subscribe for, any securities, nor shall it (or any part of it) or the fact of its release, publication or distribution, form the basis of, or be relied upon in connection with, any contract or commitment for securities in any jurisdiction.  Any such purchase or subscription must be made only on the basis of the information contained in the final admission document dated 4 July 2012 in connection with the admission of the ordinary shares of 1p each in the capital of Revolymer plc ("Ordinary Shares") to trading on AIM, a market operated by London Stock Exchange plc, which may be different from the information contained in this announcement and contains additional information.

The offer of the Ordinary Shares has not been, nor will they be, registered under the United States Securities Act of 1933, as amended ("Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States.  The Ordinary Shares may not be offered, sold, pledged or otherwise transferred or delivered within the United States or to, or for the account or benefit of, any US person. In connection with the Placing, the Ordinary Shares are being offered and sold only outside the United States to, and for the account or benefit of, non-US persons in ''offshore transactions'' within the meaning of, and in reliance on the exemption from registration provided by, Regulation S under the Securities Act.

The Ordinary Shares have not been and will not be registered under the securities legislation of Canada, South Africa, the Republic of Ireland, Japan or Australia or in any country, territory or possession where to do so would contravene local securities laws or regulations and the Ordinary Shares may not be offered or sold directly or indirectly within Canada, South Africa, the Republic of Ireland, Japan or Australia or to, or for the account of benefit of, any person within Canada, South Africa, the Republic of Ireland, Japan or Australia. The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any person to whose attention this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws in any such jurisdictions.

Any prospective investor considering investing in Revolymer is recommended to seek independent financial and legal advice. 

Panmure Gordon is regulated and authorised in the United Kingdom by the Financial Services Authority and is acting as nominated adviser and broker to Revolymer and no one else in relation to the Placing and Admission. Panmure Gordon will not regard any person other than Revolymer as its customer in relation to the Placing and Admission and Panmure Gordon will not be responsible for providing the protections afforded to its customers to any other person or for providing advice to any other person in relation to the Placing and Admission.

Forward-looking statements

All statements, other than statements of historical facts, included in this announcement, including, without limitation, those regarding Revolymer's financial position, business strategy, plans and objectives of management for future operations or statements relating to expectations in relation to dividends or any statements preceded by, followed by or that include the words "targets", "believes", "expects", "aims", "intends", "plans", "will", "may", "anticipates", "would", "could" or similar expressions or the negative thereof, are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Revolymer's control that could cause the actual results, performance, achievements of or dividends paid by Revolymer to be materially different from actual results, performance or achievements, or dividend payments expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Revolymer's net asset value, present and future business strategies and income flows and the environment in which Revolymer will operate in the future.

These forward-looking statements speak only as of the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in Revolymer's expectations with regard thereto, any new information or any change in events, conditions or circumstances on which any such statements are based, unless required to do so by law or any appropriate regulatory authority.

 

END

 

 

MSCRLMATMBIMBTT